rs17215479
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM5PP3_StrongPP5
The NM_000218.3(KCNQ1):c.643G>A(p.Val215Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V215G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.643G>A | p.Val215Met | missense_variant | 4/16 | ENST00000155840.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.643G>A | p.Val215Met | missense_variant | 4/16 | 1 | NM_000218.3 | P1 | |
KCNQ1 | ENST00000335475.6 | c.262G>A | p.Val88Met | missense_variant | 4/16 | 1 | |||
KCNQ1 | ENST00000496887.7 | c.382G>A | p.Val128Met | missense_variant | 5/16 | 5 | |||
KCNQ1 | ENST00000646564.2 | c.478-12072G>A | intron_variant |
Frequencies
GnomAD3 genomes ? AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250306Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135642
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1460824Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726760
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74306
ClinVar
Submissions by phenotype
Long QT syndrome 1 Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | deCODE genetics, Amgen | Jul 21, 2023 | The variant NM_000218.3:c.643G>A (chr11:2571363) in KCNQ1 was detected in 206 heterozygotes out of 58K WGS Icelanders (MAF= 0,178%). Following imputation in a set of 166K Icelanders (572 imputed heterozyogtes) we observed an association with an elongation of the qt interval on ECG using measurements from 80068 individuals (Effect (SD)= 0.83, P= 9.16e-31). This variant has been reported in ClinVar previously as uncertain significance. Based on ACMG criteria (PS4, PP2, PP3, PP5) this variant classifies as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 11, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In vitro functional studies demonstrated that V215M alters potassium current kinetics (Eldstrom et al., 2010; Liin et al., 2016); however, a complete loss of function was not demonstrated and it is uncertain whether these experiments replicate in vivo conditions; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26633542, 19841300, 23098067, 22949429, 25916402, 27690226, 23392653, 34426522, 19716085, 31865382, 34505893, 20421371, 16414944) - |
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 30, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 215 of the KCNQ1 protein (p.Val215Met). This variant is present in population databases (rs17215479, gnomAD 0.007%). This missense change has been observed in individuals with KCNQ1-related conditions (PMID: 16414944, 22949429, 23098067, 23392653; external communication). ClinVar contains an entry for this variant (Variation ID: 53081). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNQ1 protein function. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 20421371). For these reasons, this variant has been classified as Pathogenic. - |
Cardiac arrhythmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Sep 26, 2023 | This missense variant replaces valine with methionine at codon 215 of the KCNQ1 protein. This variant is found within a highly conserved region of the transmembrane domain S3. Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). Functional studies have shown that this variant causes a rightward shift in the voltage dependence of channel activation and changes channel activation and deactivation kinetics (PMID: 20421371, 27690226, 31865382). This variant has been reported in several heterozygous individuals affected with or suspected of having long QT syndrome (PMID: 16414944, 19716085, 19841300, 23098067, 32893267, ClinVar SCV001484536.3). The variant has also been observed in compound heterozygous state with a known pathogenic KCNQ1 variant in an individual with severe long QT syndrome in the absence of an auditory phenotype, whose father was an asymptomatic carrier with prolonged QTc interval (PMID: 23392653). This variant has been described as a founder mutation in the Icelandic population and has shown a significant association with prolonged QTc interval in a large population study (PMID: 37449562). However, compared to other pathogenic variants that cause long QT syndrome, this variant is not associated with severe clinical events such as sudden cardiac death. This variant has only been identified in 3/250306 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2020 | The c.643G>A (p.V215M) alteration is located in exon 4 (coding exon 4) of the KCNQ1 gene. This alteration results from a G to A substitution at nucleotide position 643, causing the valine (V) at amino acid position 215 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:16414944;PMID:19716085;PMID:19841300;PMID:20421371). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at